ClinicalTrials.gov record
Recruiting Phase 2 Interventional

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

ClinicalTrials.gov ID: NCT04105270

Public ClinicalTrials.gov record NCT04105270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double Blind Phase II Trial of Restorative Microbiota Therapy (RMT) in Combination With Durvalumab (MEDI4736) and Chemotherapy in Untreated Patients With Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer

Study identification

NCT ID
NCT04105270
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Masonic Cancer Center, University of Minnesota
Other
Enrollment
82 participants

Conditions and interventions

Interventions

  • Cisplatin/pemetrexed or Carboplatin/pemetrexed Drug
  • Durvalumab 1500 mg IV Drug
  • Oral Restorative Microbiota Therapy (RMT) Capsules Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2022
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027
Last update posted
Sep 10, 2025

2022 – 2028

United States locations

U.S. sites
10
U.S. states
2
U.S. cities
10
Facility City State ZIP Site status
Dr. Amit Kulkarni Phoenix Arizona 85338 Not yet recruiting
MNCCTN Essentia Health St. Joseph's Brainerd Medical Center Brainerd Minnesota 56401 Recruiting
MNCCTN Essentia Health Deer River Deer River Minnesota 56636 Recruiting
MNCCTN Essentia Health St. Mary's Detroit Lakes Clinic Detroit Lakes Minnesota 56501 Recruiting
MNCCTN Essentia Health Duluth Duluth Minnesota 55805 Recruiting
MNCCTN Essentia Health Fosston Fosston Minnesota 56542 Recruiting
MNCCTN Essentia Health Hibbing Clinic Hibbing Minnesota 55746 Recruiting
Masonic Cancer Center, University of Minnesota Minneapolis Minnesota 55455 Recruiting
MNCCTN Essentia Health Sandstone Sandstone Minnesota 550723 Recruiting
MNCCTN Essentia Health Virginia Clinic Virginia Minnesota 55792 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04105270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04105270 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →